RxSight (RXST) Invested Capital (2021 - 2023)

RxSight's Invested Capital history runs 3 years deep, the most recent figure standing at $20.0 million for Q2 2023.

• Quarterly Invested Capital fell 50.0% year-over-year to $20.0 million in Q2 2023, while the trailing twelve-month figure through Mar 2024 was $20.0 million (down 87.5% YoY) and the FY2022 annual result came in at $40.0 million, changed 0.0% from the prior year.
• Invested Capital was $20.0 million for Q2 2023 at RxSight, down from $40.0 million in the prior quarter.
• Across five years, Invested Capital topped out at $40.0 million in Q2 2021 and bottomed at $20.0 million in Q2 2023.
• A 3-year average of $37.8 million and a median of $40.0 million in 2021 frame the typical range for Invested Capital.
• Annual changes were most pronounced in 2022 — Invested Capital changed 0.0% — and 2023, when it plunged 50.0%.
• RxSight's Invested Capital stood at $40.0 million in 2021, then changed by 0.0% to $40.0 million in 2022, then plunged by 50.0% to $20.0 million in 2023.
• Business Quant data shows RXST's Invested Capital at $20.0 million in Q2 2023, $40.0 million in Q1 2023, and $40.0 million in Q4 2022.